Steinbrech, Julian; Amann, Ute; Irlbeck, Michael; Clauss, Sebastian; Strobach, Dorothea (2026): Tisdale-score-based risk stratification of QTc prolongations in hospitalized patients receiving azole antifungal therapy—a retrospective study. Frontiers in Cardiovascular Medicine, 13: 1685152. ISSN 2297-055X
Veröffentlichte Publikation
fcvm-13-1685152.pdf
Abstract
Background:
QTc prolongation can trigger potentially lethal arrhythmias. Almost all azole antifungals, which are used in vulnerable patients, prolong the QTc interval and thus, may increase arrhythmia risk. The Tisdale-risk-score allows to identify patients at risk for drug-induced QTc prolongation but has not yet been investigated in this patient population.
Objective:
To evaluate the sensitivity and specificity of the Tisdale-score with regard to detected QTc prolongations in patients prescribed systemic azole antifungals.
Methods:
For six months (12/23-05/24), prescriptions of systemic azole antifungals were retrospectively recorded in adult inpatients of all medical specialties of a university hospital. Risk factors for QTc prolongation, including concomitant drugs and ECGs, were documented and the Tisdale-score and its sensitivity and specificity were calculated.
Results:
In the study period, 319 systemic azole prescriptions (cases) were recorded for 259 patients. The median age of all cases was 61 years, 45% (143) were female. Including the systemic azole, a prescription of ≥2 QT-drugs was present in 283 (89%) cases. The median Tisdale-score was 7 (moderate risk). ECGs after azole initiation were available in 149 cases. Out of these, relevant QTc prolongations occurred in 7 cases (4.7%). Sensitivity of the Tisdale-score was 100%, specificity 30%.
Conclusion:
Patients prescribed systemic azole antifungals are at risk of QTc prolongation due to regular use of multiple QT-drugs. However, relevant QTc prolongations were rare in the patient population studied. The Tisdale-score achieved a good sensitivity for the identification of patients at risk for QTc prolongation.
| Dokumententyp: | Artikel (Klinikum der LMU) |
|---|---|
| Organisationseinheit (Fakultäten): | 18 Chemie und Pharmazie > Department für Pharmazie - Zentrum für Pharmaforschung 07 Medizin > Klinikum der LMU München > Klinik für Anaesthesiologie 07 Medizin > Klinikum der LMU München > Medizinische Klinik und Poliklinik I (Kardiologie) |
| DFG-Fachsystematik der Wissenschaftsbereiche: | Lebenswissenschaften |
| Veröffentlichungsdatum: | 15. Apr 2026 12:41 |
| Letzte Änderung: | 15. Apr 2026 12:41 |
| URI: | https://oa-fund.ub.uni-muenchen.de/id/eprint/2467 |
| DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 491502892 |
![Publikation bearbeiten['Plugin/Screen:render_action_img_suffix' not defined] Publikation bearbeiten](/style/images/action_view.png)